Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Advertising

The CEO of Novo Nordisk has publicly defended the company's decision to sue rival Eli Lilly. The lawsuit concerns Eli Lilly's advertising practices for its weight-loss drug, with Novo Nordisk asserting that competition must be fair.